The role of β-blockers in chronic heart failure <br /> <br />

Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2003, Vol 20, Issue 1

Abstract

Until recently β-blockers were contraindicated for the treatment of chronic heart failure and their administration was avoided in heart failure patients. The use of β-blockers in heart failure is justified by the fact that increased activation of the adrenergic system in heart failure results in adverse biological signals to the cardiac myocytes. While the effects of β-blockers on exercise capacity and quality of life in heart failure patients are still controversial, clinical trials clearly show improvement in left ventricular function and reduction in its size, as well as fewer hospitalizations from aggravated heart failure. Four adequately powered β-blocker trials, US Carvedilol, CIBIS II, MERIT-HF and COPERNICUS, showed that treatment with β-blockers significantly reduced total and sudden death mortality in heart failure patients. Now, β-blockers are recommended for patients with mild to severe chronic heart failure (NYHA functional class II–IV) and with depressed left ventricular function. Uncertainties still persist about the use of β-blockers in patients with NYHA functional class I and in some specific patient groups with heart failure. Treatment with β-blockers should be started at a very low initial dosage and then titrated up to the maximal tolerated dosage. Today, despite impressive results in terms of morbidity and mortality, β-blocker use in heart failure patients is limited, with only a minority of them benefitting.

Authors and Affiliations

P. GEORGAKOPOULOS, M. KYRIAKIDIS

Keywords

Related Articles

Right ovary-containing hernia

No abstract available

Antibiotic lock treatment of catheter-related sepsis

The diagnosis of catheter-related infection (CRI) is based on the presence of clinical manifestations of infection and the evidence of colonization of the catheter tip by microbes. To confirm colonization, a number of pr...

A question hovers over western society: When should its members die?

To whom the tribute "when should we die" (WSWD) is addressed? To those the answer of which is not "never." The (correct) question "when?" replaces the (wrong) demand of the era: "we should never die" ("forbidden death")....

The regional organization of the National Health System (ESY) in Greece – A brief overview of the legislative interventions to date

Since the establishment of the Greek National Health System (ESY), many efforts have been made to implement a decentralized system of organization and administration of the health services in Greece. The implementation o...

Grape allergy and co-sensitization to other food allergens

ΟBJECTIVE Reports of IgE-mediated allergic reactions to grapes and wine are limited. The object of this prospective study was to present in detail the clinical picture of patients with documented IgE mediated reactions t...

Download PDF file
  • EP ID EP112906
  • DOI -
  • Views 118
  • Downloads 0

How To Cite

P. GEORGAKOPOULOS, M. KYRIAKIDIS (2003). The role of β-blockers in chronic heart failure <br /> <br /> . Αρχεία Ελληνικής Ιατρικής, 20(1), 18-29. https://europub.co.uk./articles/-A-112906